Is Clover Health Stock a Buy?
It's not often you find the combination of a hot new investing trend and a boring old government program, but that's exactly what Clover Health (NASDAQ: CLOV) offers. The company sells Medicare Advantage plans, focusing on customer experience and leveraging machine learning and artificial intelligence to achieve better outcomes.
After exploring a traditional initial public offering and a direct listing, Clover went public in January after agreeing to combine with a special purpose acquisition company (SPAC) backed by former Facebook executive and current venture capitalist Chamath Palihapitiya. Now that the public can own a stake in the mission-driven insurance company, are the shares worth buying?
Image source: Getty Images.
Source Fool.com
